Human Reproduction vol.1 no.5 pp.291-293, 1986 Early luteal function following danazol therapy for endometriosis

article OA: closed CC0
View on OpenAlex
AI-generated summary by claude@2026-06, 2026-06-08

This study found that early luteal function, assessed by temperature, hormone levels, and endometrial biopsy, was normal in infertile women with endometriosis following danazol treatment, indicating endometrial inadequacy is not responsible for increased fetal wastage.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

'To whom reprint requests should be sent The luteal phase of 20 infertile women with endometriosis who were treated with danazol (600 mg daily for 6 months) was studied by basal body temperature, plasma progesterone (P), oestradiol (Ej) and prolactin (PRL) determination, and en-dometrial biopsy, in any one of the first three cycles after discontinuation of danazol. All endometrial specimens were noted to be fundal samples and were clearly progestational after danazol therapy. Abnormal secretory phases were detected in three patients, as in the pre-danazoJ control cycles. Moreover, plasma levels of P, Ej and PRL in post-danazol cycles were similar to those found in control cycles and fell within the normal range in all cases except for one patient having hyperprolactinaemia. In conclusion, our study shows that endometrial inadequacy is not the cause of the increas-ed fetal wastage previously reported among proximally con-ceived pregnancies after danazol therapy for endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T10:45:26.843211+00:00
License: CC0 · commercial use OK